[go: up one dir, main page]

NO884399D0 - Hjertebeskyttende middel. - Google Patents

Hjertebeskyttende middel.

Info

Publication number
NO884399D0
NO884399D0 NO884399A NO884399A NO884399D0 NO 884399 D0 NO884399 D0 NO 884399D0 NO 884399 A NO884399 A NO 884399A NO 884399 A NO884399 A NO 884399A NO 884399 D0 NO884399 D0 NO 884399D0
Authority
NO
Norway
Prior art keywords
protective agent
heart protective
heart
agent
protective
Prior art date
Application number
NO884399A
Other languages
English (en)
Other versions
NO884399L (no
Inventor
Takao Takaya
Hisashi Takasugi
Kimio Esumi
Atsushi Kuno
Hiroyoshi Sakai
Kazuhiro Maeda
Yoshie Sakamoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/184,195 external-priority patent/US4857527A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO884399D0 publication Critical patent/NO884399D0/no
Priority claimed from HU885132A external-priority patent/HUT51614A/hu
Publication of NO884399L publication Critical patent/NO884399L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO88884399A 1987-10-05 1988-10-04 Hjertebeskyttende middel. NO884399L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25177187 1987-10-05
US07/184,195 US4857527A (en) 1985-12-12 1988-04-21 Morpholine containing pyridine compounds, compositions and use
HU885132A HUT51614A (en) 1985-12-12 1988-10-04 Process for producing cardio-protective and suitable for treating ischemic illnesses pharmaceutical compositions containing nitriferous heterocyclic compounds as active agent as well as for producing the active agents

Publications (2)

Publication Number Publication Date
NO884399D0 true NO884399D0 (no) 1988-10-04
NO884399L NO884399L (no) 1989-04-06

Family

ID=27270050

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884399A NO884399L (no) 1987-10-05 1988-10-04 Hjertebeskyttende middel.

Country Status (10)

Country Link
EP (1) EP0311322B1 (no)
JP (1) JPH01207234A (no)
CN (1) CN1041589A (no)
AU (1) AU621067B2 (no)
CA (1) CA1317296C (no)
DE (1) DE3882476T2 (no)
DK (1) DK554988A (no)
ES (1) ES2058301T3 (no)
FI (1) FI884418A (no)
NO (1) NO884399L (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905526D0 (en) * 1989-03-10 1989-04-19 Fujisawa Pharmaceutical Co N-containing heterocyclic compounds,processes for the preparation thereof and composition comprising the same
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US6384058B1 (en) 1997-12-11 2002-05-07 American Home Products Corporation 2,4,6-trisubstituted pryridines with estrogenic activity and methods for the solid phase synthesis thereof
US6503917B1 (en) 1998-12-10 2003-01-07 Wyeth, Five Giralda Farms 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
JP2005524612A (ja) * 2001-12-06 2005-08-18 ファイブローゲン、インコーポレーテッド 内因性エリスロポエチン(epo)を増加させる方法
CN101664553B (zh) * 2001-12-06 2013-08-21 法布罗根股份有限公司 低氧诱导因子(HIF)α的稳定化
EP2295060B1 (en) * 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530602D0 (en) * 1985-12-12 1986-01-22 Fujisawa Pharmaceutical Co Heterocyclic compounds

Also Published As

Publication number Publication date
FI884418A (fi) 1989-04-06
FI884418A0 (fi) 1988-09-27
DK554988A (da) 1989-04-06
DE3882476T2 (de) 1993-11-11
EP0311322A2 (en) 1989-04-12
DK554988D0 (da) 1988-10-04
JPH01207234A (ja) 1989-08-21
DE3882476D1 (de) 1993-08-26
EP0311322B1 (en) 1993-07-21
EP0311322A3 (en) 1990-11-22
CA1317296C (en) 1993-05-04
AU621067B2 (en) 1992-03-05
CN1041589A (zh) 1990-04-25
NO884399L (no) 1989-04-06
ES2058301T3 (es) 1994-11-01
AU2333888A (en) 1989-06-01

Similar Documents

Publication Publication Date Title
NO883059D0 (no) Mikrobicidisk middel.
DE3876469D1 (de) Hautaequivalent.
DE3850411D1 (de) Katheter.
DE3786814D1 (de) Arteriektomie-katheter.
DE3786441D1 (de) Katheter.
DE3750239D1 (de) Katheter.
DE3678932D1 (de) Katheter.
ES2017960B3 (es) Cateter.
DE3850223D1 (de) Medizinischer Führungsdraht.
NO854349L (no) Diagnostisk middel.
DE3776264D1 (de) Venenkatheter.
DE3873024D1 (de) Atherektomie-katheter.
NO882787D0 (no) Rullestol.
NO884582D0 (no) Legeringer.
MA21229A1 (fr) Saupoudreuse .
DE3882250D1 (de) Herzdefibrillator.
DE3884692D1 (de) Defibrillator.
DE69012875D1 (de) Rettungsgestell.
FI850946A0 (fi) Medicinska plaoster.
DE3852496D1 (de) Katheter.
NO884399D0 (no) Hjertebeskyttende middel.
DK646487D0 (da) Froedesinficerende middel
DE3860318D1 (de) Gewebe-schlitzgeraet.
DK485088A (da) Antiviralt middel
NO883050D0 (no) Hjertestykke.